85 related articles for article (PubMed ID: 12975732)
1. [Incidence, pathoetiology and treatment of interferon-alpha induced neuro-psychiatric side effects].
Schäfer M; Schwaiger M
Fortschr Neurol Psychiatr; 2003 Sep; 71(9):469-76. PubMed ID: 12975732
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
Hauser P
Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha (IFNalpha) and psychiatric syndromes: a review.
Schaefer M; Engelbrecht MA; Gut O; Fiebich BL; Bauer J; Schmidt F; Grunze H; Lieb K
Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):731-46. PubMed ID: 12188106
[TBL] [Abstract][Full Text] [Related]
4. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
[TBL] [Abstract][Full Text] [Related]
5. [Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression].
Capuron L; Dantzer R; Miller AH
J Soc Biol; 2003; 197(2):151-6. PubMed ID: 12910630
[TBL] [Abstract][Full Text] [Related]
6. Interferon-induced depression in chronic hepatitis C.
Horsmans Y
J Antimicrob Chemother; 2006 Oct; 58(4):711-3. PubMed ID: 16951413
[TBL] [Abstract][Full Text] [Related]
7. Safety profile of interferon-alpha therapy.
Weiss K
Semin Oncol; 1998 Feb; 25(1 Suppl 1):9-13. PubMed ID: 9482535
[TBL] [Abstract][Full Text] [Related]
8. Mood and cognitive side effects of interferon-alpha therapy.
Valentine AD; Meyers CA; Kling MA; Richelson E; Hauser P
Semin Oncol; 1998 Feb; 25(1 Suppl 1):39-47. PubMed ID: 9482539
[TBL] [Abstract][Full Text] [Related]
9. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
[TBL] [Abstract][Full Text] [Related]
10. [Neuropsychiatric symptoms related to interferon alpha].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Kiejna A
Psychiatr Pol; 2006; 40(4):787-97. PubMed ID: 17068950
[TBL] [Abstract][Full Text] [Related]
11. [Occurrence of primary hypothyroidism in alpha-interferon treatment].
Saglietti G; Ferrari V; Luraschi A; Ripamonti G; Gioria A; Fedeli P; Bersi M
Recenti Prog Med; 1996; 87(7-8):342-5. PubMed ID: 8975336
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine treatment of depression caused by interferon-alpha.
Levenson JL; Fallon HJ
Am J Gastroenterol; 1993 May; 88(5):760-1. PubMed ID: 8480744
[TBL] [Abstract][Full Text] [Related]
13. [Interferon-alpha. Results of a pharmaco-epidemiologic study].
Grion AM; Gaion RM; Cordella L; Bano F; Cannada RA; Innamorati G; Berti T
Clin Ter; 1994 Mar; 144(3):201-11. PubMed ID: 8181216
[TBL] [Abstract][Full Text] [Related]
14. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
Schaefer M; Heinz A; Backmund M
Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
[TBL] [Abstract][Full Text] [Related]
16. A perspective on the clinical effectiveness and tolerance of interferon-alpha.
Borden EC; Parkinson D
Semin Oncol; 1998 Feb; 25(1 Suppl 1):3-8. PubMed ID: 9482534
[TBL] [Abstract][Full Text] [Related]
17. Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients.
Bannink M; Kruit WH; Van Gool AR; Mulder PG; Sleijfer S; Eggermont AM; Stoter G; Fekkes D
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):109-14. PubMed ID: 15610952
[TBL] [Abstract][Full Text] [Related]
18. Use of growth factors with antiviral therapy for chronic hepatitis C.
Curry MP; Afdhal NH
Clin Liver Dis; 2005 Aug; 9(3):439-51, vii. PubMed ID: 16023976
[TBL] [Abstract][Full Text] [Related]
19. [Psychiatric symptoms related to interferon treatment for chronic hepatitis].
Hosoda S; Kohno M; Kumada H
Seishin Shinkeigaku Zasshi; 2003; 105(6):768-86. PubMed ID: 14560593
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric complications of interferons: classification, neurochemical bases, and management.
Malek-Ahmadi P; Hilsabeck RC
Ann Clin Psychiatry; 2007; 19(2):113-23. PubMed ID: 17612851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
